Significantly lower A1C levels
- STEGLATRO 5 mg lowered A1C an average of 0.7%, from 8.2% at start
- STEGLATRO 15 mg lowered A1C an average of 0.8%, from 8.4% at start
- Placebo lowered A1C an average of 0.2%, from 8.1% at start
Clinical Results With STEGLATRO
STEGLATRO was proven to lower A1C levels in some patients
STEGLATRO was studied for 26 weeks in adults with type 2 diabetes whose A1C was not controlled with diet and exercise alone. In this clinical study, STEGLATRO helped people to:
May help reach A1C goals
In the same study, almost twice as many people who took the starting dose of STEGLATRO (5 mg) reached an A1C of less than 7% as compared to placebo.
Percent of people in the study who reached an A1C goal of less than 7%:
- ~30% who took STEGLATRO 5 mg
- ~39% who took STEGLATRO 15 mg
- ~17% who took placebo
For many adults with diabetes, the American Diabetes Association recommends an A1C goal of less than 7%. Be sure to talk to your doctor about what A1C goal is right for you.
May help you lose weight
Although it's not a weight loss medication, STEGLATRO may help you lose some weight.
The people participating in the same study lost on average 5 pounds more than those taking placebo.
Average weight loss for people in the same study:
- STEGLATRO 5 mg: people lost an average of 7 pounds from 207 pounds at start
- STEGLATRO 15 mg: people lost an average of 7 pounds from 200 pounds at start
- Placebo: people lost an average of 2 pounds from 208 pounds at start
STEGLATRO is 1 pill, taken 1 time a day in the morning, and is available in 5 or 15 mg tablets. The starting dose of STEGLATRO is 5 mg.
STEGLATRO has been tested in 7 clinical studies that looked at its benefits and safety. The studies included more than 4,800 adults with type 2 diabetes.
Is it time to add STEGLATRO?
Ask your doctor if STEGLATRO, along with diet and exercise, could help lower your A1C level.
